Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$11.83 - $24.05 $60,415 - $122,823
5,107 Added 85.12%
11,107 $190,000
Q1 2024

May 14, 2024

BUY
$12.42 - $17.29 $74,520 - $103,740
6,000 New
6,000 $93,000
Q1 2023

May 12, 2023

BUY
$56.44 - $118.81 $19,584 - $41,227
347 New
347 $20,000
Q3 2021

Nov 12, 2021

SELL
$116.17 - $194.55 $134,176 - $224,705
-1,155 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$130.4 - $225.58 $1.33 Million - $2.3 Million
-10,211 Reduced 89.84%
1,155 $256,000
Q1 2021

May 14, 2021

SELL
$124.11 - $190.17 $3.17 Million - $4.86 Million
-25,536 Reduced 69.2%
11,366 $1.5 Million
Q2 2020

Aug 14, 2020

BUY
$57.2 - $74.41 $876,990 - $1.14 Million
15,332 Added 71.08%
36,902 $2.19 Million
Q1 2020

May 14, 2020

BUY
$57.05 - $95.75 $175,200 - $294,048
3,071 Added 16.6%
21,570 $1.45 Million
Q4 2019

Feb 13, 2020

BUY
$68.3 - $93.8 $1.26 Million - $1.74 Million
18,499 New
18,499 $1.56 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.82B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.